Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00047593 · ClinicalTrials.gov registry record · Phase 3
Phase 3 Study Comparing IOP Lowering in OAG or OH in Japanese Subjects C-01-98
A Phase 3 study, sponsored by Alcon Research.
- Completed
- Registry status
- Phase 3
- Development phase
NCT00047593: Completed Phase 3 study, sponsored by Alcon Research.
NCT00047593 is a Phase 3 study that has completed, run by Alcon Research. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00047593, a Phase 3 study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- Phase 3
- Development phase
Study Summary
The purpose of this study is to evaluate safety and efficacy of two different IOP lowering medications after twelve months of treatment in Japanese subjects.
Interventions
- DRUG IOP Lowering Medications
Trial Details
| Field | Value |
|---|---|
| Start Date | 2000-01 |
| Est. Completion | 2004-07 |
| Phase | Phase 3 |
What the finished NCT00047593 record still lists
NCT00047593 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which IOP Lowering Medications is the first listed.
NCT00047593 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00047593 about?
NCT00047593 is a clinical study titled "Phase 3 Study Comparing IOP Lowering in OAG or OH in Japanese Subjects C-01-98". The purpose of this study is to evaluate safety and efficacy of two different IOP lowering medications after twelve months of treatment in Japanese subjects.
What is the current status of trial NCT00047593?
This trial is currently completed. It is a Phase 3 study. The study started on 2000-01. Estimated completion is 2004-07.
What interventions are being tested in trial NCT00047593?
The interventions under investigation include: IOP Lowering Medications (DRUG).
Who is sponsoring clinical trial NCT00047593?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia